ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Physician Assistant

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,131Medicare Part D Prescriptions Filled, Including Refills

Rank: 19 out of 887

$444K Total Retail Price of All Prescriptions

Rank: 51 out of 887

367 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
38% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

3% of this provider’s 367 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

1% of this provider’s 7,150 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $72 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 8.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
SIMVASTATIN 468 418 1 3
AMLODIPINE BESYLATE 451 412 2 5
OMEPRAZOLE 320 303 3 2
METFORMIN HCL 280 229 4 8
LISINOPRIL 229 221 5 4
LOSARTAN POTASSIUM 224 204 6 42
ATORVASTATIN CALCIUM 212 181 7 13
HYDROCHLOROTHIAZIDE 166 159 8 10
LEVOTHYROXINE SODIUM 163 147 9 9
ALLOPURINOL 156 135 10 66
SYNTHROID 154 132 11 52
FENOFIBRATE 134 127 12 87
RAMIPRIL 133 95 13 121
METOPROLOL SUCCINATE 122 77 14 19
PRAVASTATIN SODIUM 117 112 15 12
METOPROLOL TARTRATE 111 87 16 16
ACTOS 106 98 17 101
TRAMADOL HCL 103 85 18 15
CITALOPRAM HBR 99 82 19 23
ZETIA 98 89 20 118
LISINOPRIL-HYDROCHLOROTHIAZIDE 90 90 21 22
ALENDRONATE SODIUM 86 86 22 57
CARVEDILOL 85 85 23 24
LEVOXYL 85 85 23 158
CRESTOR 84 71 25 25
POTASSIUM CHLORIDE 81 81 26 21
FUROSEMIDE 78 53 27 7
GABAPENTIN 78 61 27 6
MELOXICAM 78 76 27 28
METFORMIN HCL ER 72 60 30 50
PANTOPRAZOLE SODIUM 71 57 31 47
TRICOR 69 58 32 173
GLIPIZIDE XL 69 66 32 106
BUSPIRONE HCL 67 54 34 105
GLIPIZIDE ER 65 51 35 144
HYDRALAZINE HCL 62 62 36 139
PROAIR HFA 62 41 36 39
GLIMEPIRIDE 61 50 38 54
CLONIDINE HCL 57 45 39 76
LOSARTAN-HYDROCHLOROTHIAZIDE 57 46 39 68
ATENOLOL 56 56 41 37
ESCITALOPRAM OXALATE 54 43 42 96
LOVASTATIN 53 52 43 58
SPIRIVA 51 49 44 45
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 4, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.